Under Atmanirbhar Bharat 3.0 Mission COVID Suraksha was announced by the Government of India, to accelerate the development and production of Indigenous COVID Vaccines. This is being implemented by Department of Biotechnology Govt of India. According to the Ministry of Science and Technology , the Department of Biotechnology will provide financial support in manufacturing,” Department of Biotechnology is providing financial support as Grant to vaccine manufacturing facilities for enhanced production capacities. Current production capacity of indigenously developed Covaxin vaccine will be doubled by May-June 2021,”
It’s expected that the production will be increased more till month of July, “Nearly 6-7 fold by July – August 2021 i.e increasing the production from 1 crore vaccine doses in April, 2021 to 6-7 crore vaccine dose/month in July – August. It’s expected to reach nearly 10 crore doses per month by Sep 2021,”
